Client News
InflaRx Reports Second Quarter 2023 Financial Results & Operating Update
10th August 2023
Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom
1st August 2023
Destiny Pharma: Publication of new data demonstrates significantly superior efficacy of XF-73 compared to a leading topical antibiotic against MRSA in skin infection models
31st July 2023
Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
20th July 2023
leon-nanodrugs appoints Dr. Hans Frickel as Chief Executive Officer
18th July 2023
Mainz Biomed Announces Collaboration with Fugene Genetics in Israel
18th July 2023
AATec Medical Announces its Launch with EUR 2.7 million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin
17th July 2023
Rentschler Biopharma: Dr. Dominik Kugelstadt joins Rentschler Biopharma as Head of Clinical and Commercial Manufacturing, Laupheim
12th July 2023
There is no more content to load